Pre-emptive treatment of fungal infection based on plasma β-D-glucan levels after gastric surgery for gastric cancer in elderly patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 9, 2013, Pages 1457-1461

  Namikawa, Tsutomu ^a   Kitagawa, Hiroyuki ^a   Yamatsuji, Tomoki ^b   Naomoto, Yoshio ^b   Kobayashi, Michiya ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Fungal infection; Gastric cancer; Gastric surgery; Pre emptive treatment

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; C REACTIVE PROTEIN; FLUCONAZOLE;

AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD LEVEL; CANCER SURGERY; CANDIDA; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; GASTRECTOMY; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; STOMACH SURGERY; SURGICAL INFECTION; SYSTEMIC MYCOSIS;

FUNGAL INFECTION; GASTRIC CANCER; GASTRIC SURGERY; PRE-EMPTIVE TREATMENT;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BETA-GLUCANS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; GASTRECTOMY; HUMANS; MALE; MYCOSES; NEOPLASM STAGING; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84897583625     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12219     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2006. CA Cancer J. Clin. 2006; 56: 106-130.
2. Isobe Y, Nashimoto A, Akazawa K etal. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 2011; 14: 301-316.
3. Otsuji E, Fujiyama J, Takagi T etal. Results of total gastrectomy with extended lymphadenectomy for gastric cancer in elderly patients. J. Surg. Oncol. 2005; 91: 232-236.
4. Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY, P'eng FK. Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J. Surg. 2000; 24: 465-472.
5. Katai H, Sasako M, Sano T, Fukagawa T. Gastric cancer surgery in the elderly without operative mortality. Surg. Oncol. 2004; 13: 235-238.
6. Gretschel S, Estevez-Schwarz L, Hünerbein M, Schneider U, Schlag PM. Gastric cancer surgery in elderly patients. World J. Surg. 2006; 30: 1468-1474.
7. Obayashi T, Yoshida M, Mori T etal. Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
8. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1, 3)-β-D-Glucan as a prognostic marker of treatment response in invasive candidiasis. Clin. Infect. Dis. 2012; 55: 521-526.
9. De Pauw B, Walsh TJ, Donnelly JP etal. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008; 46: 1813-1821.
10. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123.
11. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edn. New York: Wiley-Blackwell, 2009.
12. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Manual. Atlanta: CDC; 1999. Surgical patient surveillance component: p.XI 1-10, XII 25, 31; XIII 11-3.
13. Goldberg E, Gafter-Gvili A, Robenshtok E, Leibovici L, Paul M. Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis. Eur. J. Cancer 2008; 44: 2192-2203.
14. Leenders NH, Oosterheert JJ, Ekkelenkamp MB, De Lange DW, Hoepelman AI, Peters EJ. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy? Int. J. Infect. Dis. 2011; 15: e453-e458.
15. Cordonnier C, Pautas C, Maury S etal. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin. Infect. Dis. 2009; 48: 1042-1051.
16. Robenshtok E, Gafter-Gvili A, Goldberg E etal. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J. Clin. Oncol. 2007; 25: 5471-5489.
17. Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002; 94: 3230-3246.
18. Gøtzsche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. BMJ 1997; 314: 1238-1244.
19. Lantos J, Földi V, Roth E, Wéber G, Bogár L, Csontos C. Burn trauma induces early HMGB1 release in patients: its correlation with cytokines. Shock 2010; 33: 562-567.
20. Akamatsu N, Sugawara Y, Kaneko J, Tamura S, Makuuchi M. Preemptive treatment of fungal infection based on plasma (1→3)β-D-glucan levels after liver transplantation. Infection 2007; 35: 346-351.
21. Orsenigo E, Tomajer V, Palo SD etal. Impact of age on postoperative outcomes in 1118 gastric cancer patients undergoing surgical treatment. Gastric Cancer 2007; 10: 39-44.
22. Kunisaki C, Akiyama H, Nomura M etal. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am. J. Surg. 2006; 191: 216-224.
23. Walsh TJ, Lee J, Lecciones J etal. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Rev. Infect. Dis. 1991; 13: 496-503.